Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes
(Article in Japanese) Tsubata S, Ogawa K, Hirano M, et al
Some patients have a sensitivity to copper that manifests as more pronounced injection site discomfort
Give each injection site at least a week of rest before returning to it
US$ 29.68
US$ 20.00
US$ 26.56
US$ 28.70
US$ 20.44
US$ 25.29
US$ 24.54
US$ 23.31
/assets/production/practices/bb098bde1976b73281d3b963c3dfa64815de4cfc/images/2780379.jpeg)
US$ 25.87
